Related Experiment Video
Updated: Mar 19, 2026
05:08
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
17.8K
Self-assembly drug conjugates for anticancer treatment
Gaia Fumagalli1, Cristina Marucci1, Michael S Christodoulou1
1Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy.
Drug Discovery Today
|June 23, 2016
Summary
Self-assembling drug conjugates form nanoparticles for enhanced cancer treatment. This nanotechnology approach improves drug delivery, increases tumor concentration, and reduces side effects, offering a promising therapeutic strategy.
Area of Science:
- Nanotechnology
- Drug Delivery
- Cancer Therapeutics
Background:
- Self-assembly drug conjugates offer a promising strategy to enhance the efficacy and safety of potent small molecule drugs.
- These conjugates can self-assemble in aqueous environments to form nanoparticles (NPs).
Purpose of the Study:
- To review nanotechnology-based self-assembly drug delivery approaches.
- To focus on prodrugs capable of forming NPs via self-assembly.
- To summarize current perspectives and challenges in cancer treatment using these methods.
Main Methods:
- Literature review of self-assembly drug conjugate preparation.
- Analysis of nanotechnology-based self-assembly drug delivery systems.
- Focus on prodrugs forming nanoparticles.
Main Results:
- Self-assembly drug conjugates form nanoparticles (NPs) with several advantages: ease of preparation, high local drug concentration in tumors, and reduced drug side effects.
- These NPs improve drug pharmacokinetic properties.
Conclusions:
- Nanotechnology-based self-assembly drug delivery holds significant potential for improving cancer treatment.
- Further research and development are needed to overcome existing challenges for successful clinical translation.
More Related Videos
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82
01:24Modified-Release Drug Delivery Systems: Site-Targeted
74
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
74
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:14Phase II Conjugation Reactions: Overview
1.1K
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
1.1K
02:41Protein Complex Assembly
17.0K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
17.0K